Henry Schein acquires vaccine provider
By HME News Staff
Updated 10:42 AM CST, Wed March 5, 2025
MELVILLE, N.Y. – Henry Schein has acquired R. Weinstein, Inc., a provider of vaccines, medical-surgical products and equipment to Hawaii-based health care facilities and practitioners. Headquartered in Honolulu, R. Weinstein was established in 1984 and reported sales of approximately $11 million in 2024. “Our investment in R. Weinstein helps position us for long-term success across the Hawaiian health care sector by expanding our geographic footprint, growing our customer base and leveraging the expertise of our new colleagues,” said Stanley M. Bergman, chairman of the board and CEO of Henry Schein. “We welcome the R. Weinstein team and look forward to continuing to help Hawaii-based health care practitioners deliver the best quality patient care while operating more efficient and profitable practices.” The financial terms of the transaction were not disclosed. The acquisition of R. Weinstein strengthens Henry Schein’s presence across the Hawaiian Islands while offering R. Weinstein’s customers access to the company’s expanded distribution network and comprehensive portfolio of products, services, technology and supply chain solutions.
Comments